Search Results - Kevin Nash

Refine Results
  1. 1
    Neuroinflammation and fractalkine signaling in Alzheimer’s disease

    Neuroinflammation and fractalkine signaling in Alzheimer’s disease by Dylan J. Finneran, Kevin Nash

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Complete In Vitro Reconstitution of Adeno-Associated Virus DNA Replication Requires the Minichromosome Maintenance Complex Proteins

    Complete In Vitro Reconstitution of Adeno-Associated Virus DNA Replication Requires the Minichromosome Maintenance Complex Proteins by Kevin Nash, Weijun Chen, Nicholas Muzyczka

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases

    Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases by Aurélie Joly‐Amado, Neel Kulkarni, Kevin Nash

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein

    Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein by Kevin Nash, Weijun Chen, Max Salganik, Nicholas Muzyczka

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration

    Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration by Bethany Grimmig, Seol-Hee Kim, Kevin Nash, Paula C. Bickford, R. Douglas Shytle

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease

    T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease by Meena S. Subbarayan, Charles E. Hudson, Lauren D. Moss, Kevin Nash, Paula C. Bickford

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

    Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice by Edgardo Rodríguez-Lebrón, Eileen M. Denovan‐Wright, Kevin Nash, Alfred S. Lewin, Ronald J. Mandel

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease

    Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease by Beth Grimmig, Lauren Daly, Meena S. Subbarayan, Ched Hudson, Robert Williamson, Kevin Nash, Paula C. Bickford

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease

    The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease by Josh M. Morganti, Kevin Nash, Bethany Grimmig, Sonali Ranjit, Brent J. Small, Paula C. Bickford, Carmelina Gemma

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration

    Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration by Kevin Nash, Peter Moran, Dylan J. Finneran, Charles E. Hudson, Jesse Robinson, Dave Morgan, Paula C. Bickford

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders

    Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders by Ronald J. Mandel, Fredric P. Manfredsson, Kevin D. Foust, Aaron Rising, Sharon Reimsnider, Kevin Nash, Corinna Bürger

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Lung infection by Pseudomonas aeruginosa induces neuroinflammation and blood–brain barrier dysfunction in mice

    Lung infection by Pseudomonas aeruginosa induces neuroinflammation and blood–brain barrier dysfunction in mice by Nuria Villalba, Yonggang Ma, Sarah A. Gahan, Aurélie Joly‐Amado, Sam Spence, Xiaoyuan Yang, Kevin Nash, Sarah Y. Yuan

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina

    Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina by Derek Rodriguez, Kaira A. Church, Chelsea T. Smith, Difernando Vanegas, Sandra M. Cardona, Isabel A. Muzzio, Kevin Nash, Astrid E. Cardona

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice

    Adeno-associated Viral (AAV) Serotype 5 Vector Mediated Gene Delivery of Endothelin-converting Enzyme Reduces Aβ Deposits in APP + PS1 Transgenic Mice by Nikisha Carty, Kevin Nash, Daniel C. Lee, Mary P. Mercer, Paul E. Gottschall, Craig Meyers, Nicholas Muzyczka, Marcia N. Gordon, Dave Morgan

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice

    Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice by Aimee N. Winter, Meena S. Subbarayan, Bethany Grimmig, Jason A. Weesner, Lauren D. Moss, Melinda Peters, Edwin J. Weeber, Kevin Nash, Paula C. Bickford

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain

    Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain by Nikisha Carty, Daniel C. Lee, Chad A. Dickey, Carolina Ceballos‐Diaz, Karen Jansen‐West, Todd E. Golde, Marcia N. Gordon, Dave Morgan, Kevin Nash

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System

    Successful Production of Pseudotyped rAAV Vectors Using a Modified Baculovirus Expression System by Erik Kohlbrenner, George Aslanidi, Kevin Nash, Stanislav Shklyaev, Martha Campbell‐Thompson, Barry J. Byrne, Richard O. Snyder, Nicholas Muzyczka, Kenneth H. Warrington, Sergei Zolotukhin

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model

    TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model by Frank Zamudio, Anjanet Loon, Shayna Smeltzer, Khawla Benyamine, Nanda Kumar N. Shanmugam, Nicholas J. Stewart, Daniel C. Lee, Kevin Nash, Maj‐Linda B. Selenica

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease

    Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disea... by Md Shahaduzzaman, Kevin Nash, Charles E. Hudson, Sharif Masroor, Bethany Grimmig, Xiaoyang Lin, Ge Bai, Hui Liu, Kenneth E. Ugen, Chuanhai Cao, Paula C. Bickford

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration

    In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration by Oleg S. Gorbatyuk, Shoudong Li, Kevin Nash, Marina S. Gorbatyuk, Alfred S. Lewin, Layla F Sullivan, Ronald J. Mandel, Weijun Chen, Craig Meyers, Fredric P. Manfredsson, Nicholas Muzyczka

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: